Journal
NATURE MEDICINE
Volume 25, Issue 1, Pages 30-36Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41591-018-0307-0
Keywords
-
Funding
- Guangzhou Medical University, Guangzhou Regenerative Medicine and Health Guangdong Laboratory [B185004102, B185004075]
- NATIONAL LIBRARY OF MEDICINE [T15LM011271] Funding Source: NIH RePORTER
Ask authors/readers for more resources
The development of artificial intelligence (AI)-based technologies in medicine is advancing rapidly, but real-world clinical implementation has not yet become a reality. Here we review some of the key practical issues surrounding the implementation of AI into existing clinical workflows, including data sharing and privacy, transparency of algorithms, data standardization, and interoperability across multiple platforms, and concern for patient safety. We summarize the current regulatory environment in the United States and highlight comparisons with other regions in the world, notably Europe and China.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available